LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged due process · clear

PTAB

Federal Circuit Holds That the PTAB Does Not Have an Impermissible Incentive to Institute IPRs

MOBILITY WORKX, LLC v. UNIFIED PATENTS, LLC Before Newman, Schall, and Dyk. Appeal from the Patent Trial and Appeal Board. Summary: Fee-funded structure of AIA review proceedings does not violate due process. After inter partes review (“IPR”),…

October 14, 2021·PTAB·1 min read
PTAB

Due Process Challenges to the PTAB Fee Model?

If the PTAB Fee Model is Biased, Patent Owners Have Much Bigger Problems Recently, a due process challenge has been raised to the PTAB fee model in New Vision Gaming v. SG Gaming Inc. The argument, in a nutshell, is that because the fees for AIA trial…

August 14, 2020·PTAB·3 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data